Form 4: L3Harris CEO Sells Shares After Option Exercise

L3Harris Technologies CEO Christopher Kubasik executed a pre-planned sale of 40,138 shares of common stock after exercising stock options.

Summary

• Christopher E. Kubasik, Chair and CEO of L3Harris Technologies, Inc., engaged in a pre-planned transaction under Rule 10b5-1(c).
• On August 11, 2025, Kubasik exercised 40,138 non-qualified stock options with an exercise price of $149.31 per share.
• Concurrently, he sold 40,138 shares of common stock at a weighted average price of $269.52 per share, with prices ranging from $267.99 to $270.63.
• Following these transactions, Kubasik directly owns 145,577.82 shares and indirectly owns 30,000 shares through a grantor retained annuity trust.
• The options exercised were granted on June 29, 2019, and were set to expire on December 20, 2027.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. While it's a sale by a CEO, it's a pre-planned transaction (Rule 10b5-1) and represents a profitable exercise of options, which is generally a positive for the insider. It does not indicate a lack of confidence in the company.

Positives

• The transaction was pre-planned under Rule 10b5-1(c), indicating a structured approach to insider trading and potentially reducing concerns about opportunistic selling.
• The sale price of $269.52 per share is significantly higher than the option exercise price of $149.31, indicating a profitable transaction for the insider.

Negatives

• A sale of shares by a CEO, even if pre-planned, can sometimes be perceived negatively by investors as it reduces the insider's direct equity stake.

Future Outlook

No future outlook or guidance is provided in this Form 4 filing, as it primarily reports an insider transaction.

Industry Context

This is an insider transaction report for a senior executive of L3Harris Technologies, a major defense contractor. It reflects an individual's financial planning and compensation realization rather than broader industry trends or company-specific operational performance.

Comparison to Industry Standards

• This filing reports an insider transaction, which is a standard disclosure for executive compensation and liquidity management within publicly traded companies. The transaction itself, involving the exercise of stock options and subsequent sale of shares, is a common practice for executives to realize value from their equity compensation.
• The use of a Rule 10b5-1 plan for the transaction aligns with best practices for insider trading, providing a pre-arranged schedule for trades and mitigating concerns about opportunistic trading based on non-public information, a standard observed across the industry for executive stock plans.

Related Party Transactions

• Indirect beneficial ownership of 30,000 shares is held through a grantor retained annuity trust, which is a common estate planning vehicle for executives.

Stakeholder Impact

• Shareholders: A CEO selling shares might be viewed with slight caution, but the Rule 10b5-1 plan mitigates concerns about opportunistic selling. The transaction itself does not directly impact company operations or financial health.
• Employees, Customers, Suppliers, Creditors: No direct impact from this insider transaction.

Key Dates

Recommendation

This Form 4 filing details a pre-planned transaction by the CEO, Christopher Kubasik, involving the exercise of stock options and the subsequent sale of shares. The transaction is a routine liquidity event for an executive and was conducted under a Rule 10b5-1 plan, which indicates it was scheduled in advance and not based on new, non-public information. The sale price significantly exceeds the option exercise price, representing a profitable outcome for the insider. While a sale by a CEO can sometimes raise questions, the pre-planned nature and the context of option exercise suggest it's not a signal of negative sentiment towards the company's future prospects. Therefore, the filing itself does not provide new information that would warrant a change in investment recommendation; a 'hold' recommendation remains appropriate based solely on this filing.

Keywords

L3Harris Technologies, LHX, Christopher Kubasik, SEC Form 4, Insider Trading, Stock Options, Share Sale, Rule 10b5-1, CEO